Form 4: Nascent Biotech CFO Acquires Shares as Part of Employment Contract

Lowell Thomas Holden, CFO of Nascent Biotech Inc., acquired 119,650 shares of common stock as part of his employment contract on December 29, 2023.

Summary

• On December 29, 2023, Lowell Thomas Holden, the CFO of Nascent Biotech Inc., acquired 119,650 shares of common stock.
• The acquisition was part of his employment contract with the company.
• The price per share was $0.17.
• Following the transaction, Holden directly owns 9,796,977 shares of common stock.
• Holden also indirectly owns 2,000,000 shares through his spouse.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as the CFO acquiring shares as part of his employment contract indicates alignment with the company's interests. It's a routine transaction, but still a positive signal.

Positives

• The acquisition of shares by the CFO demonstrates his commitment to the company.
• The shares were granted as part of his employment contract, aligning his interests with the company's success.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder confidence due to the CFO's increased stake in the company.

Key Dates

Keywords

Nascent Biotech, NBIO, Lowell Thomas Holden, CFO, Form 4, Share Acquisition, Employment Contract, Beneficial Ownership